OR-LATTICE-SEMICONDUCTOR
8.12.2020 22:02:11 CET | Business Wire | Press release
Lattice Semiconductor Corporation (NASDAQ: LSCC), the low power programmable leader, today announced the Lattice Mach™-NX FPGA family, the second generation in its successful line of secure control FPGAs. Building on the capabilities of the Lattice MachXO3D™ family announced in 2019, Mach-NX FPGAs deliver heightened security features and the fast, power-efficient processing needed to implement a real-time Hardware Root-of-Trust (HRoT) on future server platforms, as well as computing, communications, industrial, and automotive systems. Mach-NX marks the third FPGA family developed on the Lattice Nexus™ FPGA platform in a year.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201208005194/en/
“The race is on between bad actors trying to exploit firmware vulnerabilities and developers designing server platforms with the security features and performance to stop them,” said Patrick Moorhead, president and founder of Moor Insights & Strategy. “Protecting systems better requires a real-time HRoT with support for stronger cryptography algorithms like ECC 384 and new, robust data security protocols like SPDM. I believe technologies like Lattice’s Mach FPGA families can simplify and accelerate implementation of these technologies for server OEMs looking to better secure their platforms against cyberattack and IP theft.”
Esam Elashmawi, Chief Strategy and Marketing Officer at Lattice, added: “Securing systems against unauthorized firmware access goes beyond establishing a HRoT at boot. It also requires that components used to build the system are not compromised as they move through the global supply chain. When combined with the additional protection afforded by our SupplyGuard security service, Lattice Mach-NX FPGAs can protect a system throughout its entire lifecycle: beginning at the time components start moving through the supply chain, through initial product assembly, end-product shipping, integration, and throughout the product’s operational lifetime.”
Building on the system control capabilities of the Mach family, Mach-NX FPGAs combine a secure enclave (an advanced, 384-bit hardware-based crypto engine supporting reprogrammable bitstream protection) with a logic cell (LC) and I/O block. The secure enclave helps secure firmware, and the LC and I/O block enable system control functions such as power management and fan control. Mach-NX FPGAs can verify and install the over-the-air firmware updates that keep systems compliant with evolving security guidelines and protocols. The Mach-NX FPGA’s parallel processing architecture and dual-boot flash memory configuration provide the near instantaneous response times needed to detect and recover from attacks (a level of performance beyond the capabilities of other HRoT platforms like MCUs). Mach-NX FPGAs will support the Lattice Sentry™ solutions stack, a robust combination of customizable embedded software, reference designs, IP, and development tools to accelerate the implementation of secure systems compliant with NIST Platform Firmware Resiliency (PFR) Guidelines (NIST SP-800-193).
Key features of the Mach-NX family include:
- Secure system control – Mach-NX FPGAs’ logic (up to 11K LCs) and high I/O count (up to 379) enable fast and secure system control. Lattice is a long-standing leader in programmable logic for system control. Mach FPGAs have an attach rate of over 80 percent on current shipping server platforms.
- Robust standards and protocol compliance – the Mach-NX FPGAs’ 384-bit hardware crypto engine supports quick-and-easy implementation of leading-edge cryptography like ECC 384 and industry-standard security protocols such as NIST SP-800-193 and MCTP-SPDM . Upcoming server platforms will require support for these protocols.
- End-to-end supply chain protection – Mach-NX FPGAs are supported by the Lattice SupplyGuard™ supply chain security subscription service. SupplyGuard gives OEMs and ODMs peace-of-mind by tracking locked Lattice FPGAs through their entire lifecycle, from the point of manufacture, through transport via the global supply chain, system integration and assembly, initial configuration, and deployment.
- Rapidly customizable – the Lattice Propel™ design environment accelerates design of a customized, PFR-compliant HRoT solution. The tool uses a GUI-based development environment that allows developers to create PFR solutions while minimizing the need to write RTL code.
For More Information
To learn more about the Lattice technologies mentioned above, please visit:
- www.latticesemi.com/Mach-NX
- www.latticesemi.com/LatticeNexus
- www.latticesemi.com/MachXO3D
- www.latticesemi.com/LatticeSentry
- www.latticesemi.com/LatticeSupplyGuard
- www.latticesemi.com/LatticePropel
About Lattice Semiconductor
Lattice Semiconductor (NASDAQ: LSCC) is the low power programmable leader. We solve customer problems across the network, from the Edge to the Cloud, in the growing communications, computing, industrial, automotive, and consumer markets. Our technology, long-standing relationships, and commitment to world-class support lets our customers quickly and easily unleash their innovation to create a smart, secure and connected world.
For more information about Lattice, please visit www.latticesemi.com . You can also follow us via LinkedIn , Twitter , Facebook , YouTube , WeChat , Weibo or Youku .
Lattice Semiconductor Corporation, Lattice Semiconductor (& design) and specific product designations are either registered trademarks or trademarks of Lattice Semiconductor Corporation or its subsidiaries in the United States and/or other countries.
GENERAL NOTICE: Other product names used in this publication are for identification purposes only and may be trademarks of their respective holders.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201208005194/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
